Overview
o2h discovery is a Contract Research Organization providing integrated drug discovery services including hit identification, lead optimization, discovery chemistry, biology, and pharmacology. Operating from research centers in Cambridge, UK and Ahmedabad, India, the company supports clients through hit-lead-optimization programs leading to patent and IND filing with capabilities in fragment-based screening, custom synthesis, and computational chemistry.
Frequently asked questions
- What drug discovery services does o2h discovery offer?
- o2h discovery provides an integrated drug discovery platform including hit identification through label and label-free screening platforms, lead optimization, discovery chemistry at mg/g scale, biology services across therapeutic areas, pharmacology, and computational chemistry. The company supports clients from primary screening through orthogonal validation and into patent and IND filing.
- Where are o2h discovery's research facilities located?
- o2h discovery operates state-of-the-art research centers in Cambridge, UK (located at The Mill SciTech Park) and Ahmedabad, India, providing geographic flexibility for drug discovery projects.
- What chemistry capabilities does o2h discovery provide?
- o2h discovery offers custom synthesis services at discovery scale, medicinal chemistry support, and computational chemistry services. Computational chemists provide both stand-alone in silico screening projects and support for medicinal chemistry programs, with expertise in fragment-based screening and custom compound libraries.
- How long has o2h discovery been operating?
- Founded in 2005, o2h discovery has over 20 years of experience as a Contract Research Organization with established expertise in executing complete drug discovery programs from hit identification through pre-clinical development.
- What is the parent organization of o2h discovery?
- o2h discovery is part of o2h group, which operates six symbiotic verticals including o2h ventures, o2h technology, o2h therapeutics, o2h co-work, and o2h community, providing integrated support across biotech, small molecule, biologics, and digital health sectors.